Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Description Cagrilintide is an investigational, long-acting synthetic peptide that acts as a dual amylin and calcitonin receptor agonist (DACRA), primarily under development for the treatment of obesity and type 2 diabetes
No claims are made regarding its safety or efficacy for any therapeutic, diagnostic, or clinical application
Investigation of combination therapies, including combinations of these peptides with each other or with other therapeutic modalities, could potentially improve therapeutic efficacy for certain applications
L-carnitine facilitates the mitochondrial eta-oxidation process and energy production by mediating the transport of long-chain fatty acids into the mitochondrial matrix (Ribas et al
Cancer: Increases the risk of certain cancers by 50%, compared to those with a healthy weight
US$ 28.67
US$ 25.23
US$ 25.78
